We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
KisorDF, SchmithVD, WarginWA, et al. Importance of the organ-independent elimination of cisatracurium.Anesth Analg1996; 63: 1065–1071.Google Scholar
RevesJG. Nonvolatile anesthetic agents. In: MorganE, MikhailMS, MurrayMJ, eds. Clinical Anesthesiology. New York, USA: McGraw-Hill Companies, 2002: 151–178.
WulfH, KahlM, LedowskiT. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total IV anesthesia.Br J Anaesth1998; 80: 308–312.Google Scholar
OrtizGJ, PercazBJ. The effect of anesthetic technique on recovery from neuromuscular blockade with cisatracurium.Rev Esp Anestesiol Reanim2001; 48: 117–121.Google Scholar
JellishSW, BrodyM, SawickiK, SlogoffS. Recovery from neuromuscular blockade after bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics.Anesth Analg2000; 91: 1250–1255.Google Scholar
MelloniC, AntoliniF. Effective doses of cisatracurium. Potentiation by sevoflurane and increasing requirements with age.Minerva Anestesiol2000; 66: 115–121.Google Scholar
HemmerlingTM, SchuettlerJ, SchwildenH. Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol.Can J Anaesth2001; 48: 532–537.Google Scholar